InVite Study in Metastatic Breast Cancer/Avastin - 23andMe and Genentech study (U.S.)

InVite Study in Metastatic Breast Cancer - 23andMe

Who is Eligible

1. Diagnosed with breast cancer by a medical professional
2. Currently have metastatic (stage IV) or recurrent breast cancer
3. Treated with bevacizumab (also known as Avastin®) at any point in 2010 and/or 2011*
4. Live in the United States
5. Age 18 or older

*If you were treated with bevacizumab (also known as Avastin®) after 2011, and are interested in possible future opportunities to participate, please email
invite-study@23andme.com.

What You Get

• Convenient and easy opportunity to participate in new type of research
• Help advance medical research in metastatic breast cancer and its treatment
• Receive updates about research progress and discoveries
• Learn about your health and ancestry through FREE access to 23andMe's Personal Genome Service